
Jeanette M. Lieb
Examiner (ID: 4527, Phone: (571)270-3490 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1675, 1654 |
| Total Applications | 1052 |
| Issued Applications | 767 |
| Pending Applications | 108 |
| Abandoned Applications | 207 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18877472
[patent_doc_number] => 20240000841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => LIGAND REGULATED PROTEIN-PROTEIN INTERACTION SYSTEM
[patent_app_type] => utility
[patent_app_number] => 18/312330
[patent_app_country] => US
[patent_app_date] => 2023-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30232
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18312330
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/312330 | Ligand regulated protein-protein interaction system | May 3, 2023 | Issued |
Array
(
[id] => 18739582
[patent_doc_number] => 20230348538
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => METHOD FOR TREATMENT OF DRY EYE COMPRISNG APPLYING P55PIK INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 18/312574
[patent_app_country] => US
[patent_app_date] => 2023-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6758
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18312574
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/312574 | METHOD FOR TREATMENT OF DRY EYE COMPRISNG APPLYING P55PIK INHIBITOR | May 3, 2023 | Pending |
Array
(
[id] => 18752905
[patent_doc_number] => 20230356187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => IMMUNOGLOBULIN-BINDING PROTEIN VARIANTS WITH INCREASED ALKALI-TOLERANCE AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/305522
[patent_app_country] => US
[patent_app_date] => 2023-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12940
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18305522
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/305522 | IMMUNOGLOBULIN-BINDING PROTEIN VARIANTS WITH INCREASED ALKALI-TOLERANCE AND USE THEREOF | Apr 23, 2023 | Pending |
Array
(
[id] => 19020146
[patent_doc_number] => 20240076317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => CELL-REACTIVE, LONG-ACTING, OR TARGETED COMPSTATIN ANALOGS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/133372
[patent_app_country] => US
[patent_app_date] => 2023-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37502
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18133372
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/133372 | CELL-REACTIVE, LONG-ACTING, OR TARGETED COMPSTATIN ANALOGS AND USES THEREOF | Apr 10, 2023 | Abandoned |
Array
(
[id] => 18536155
[patent_doc_number] => 20230241243
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => CARRIER PARTICLE-DRUG CONJUGATES, SELF-IMMOLATIVE LINKERS, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/297200
[patent_app_country] => US
[patent_app_date] => 2023-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 101757
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18297200
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/297200 | CARRIER PARTICLE-DRUG CONJUGATES, SELF-IMMOLATIVE LINKERS, AND USES THEREOF | Apr 6, 2023 | Pending |
Array
(
[id] => 19060193
[patent_doc_number] => 11939402
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-26
[patent_title] => Antifungal peptides, compounds including the same, and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 18/128062
[patent_app_country] => US
[patent_app_date] => 2023-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 8788
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18128062
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/128062 | Antifungal peptides, compounds including the same, and methods of use thereof | Mar 28, 2023 | Issued |
Array
(
[id] => 19651279
[patent_doc_number] => 12173048
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-24
[patent_title] => Collagen fiber-based ink and methods of use for bioprinting
[patent_app_type] => utility
[patent_app_number] => 18/173506
[patent_app_country] => US
[patent_app_date] => 2023-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12865
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18173506
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/173506 | Collagen fiber-based ink and methods of use for bioprinting | Feb 22, 2023 | Issued |
Array
(
[id] => 20385472
[patent_doc_number] => 12485182
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-02
[patent_title] => Proteoglycan mimetics for enhanced wound healing, angiogenesis, and vascular repair
[patent_app_type] => utility
[patent_app_number] => 18/168792
[patent_app_country] => US
[patent_app_date] => 2023-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 37
[patent_no_of_words] => 17056
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18168792
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/168792 | Proteoglycan mimetics for enhanced wound healing, angiogenesis, and vascular repair | Feb 13, 2023 | Issued |
Array
(
[id] => 18879086
[patent_doc_number] => 20240002455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => CHILI PEPPER SEED ISOLATED OLIGOPEPTIDE FTLE AND APPLICATION THEREOF IN PREVENTING OR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 18/169149
[patent_app_country] => US
[patent_app_date] => 2023-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2916
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18169149
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/169149 | Chili pepper seed isolated oligopeptide FTLE and application thereof in preventing or treating cancer | Feb 13, 2023 | Issued |
Array
(
[id] => 18628203
[patent_doc_number] => 20230287052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => PEPTIDE COMPOSITIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/159021
[patent_app_country] => US
[patent_app_date] => 2023-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20393
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18159021
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/159021 | Peptide compositions and methods of use | Jan 23, 2023 | Issued |
Array
(
[id] => 19862277
[patent_doc_number] => 20250101063
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-27
[patent_title] => POLYPEPTIDE COMPOUND AND USE THEREOF IN TREATMENT OF ENTERITIS
[patent_app_type] => utility
[patent_app_number] => 18/730237
[patent_app_country] => US
[patent_app_date] => 2023-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19372
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18730237
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/730237 | POLYPEPTIDE COMPOUND AND USE THEREOF IN TREATMENT OF ENTERITIS | Jan 18, 2023 | Pending |
Array
(
[id] => 20301221
[patent_doc_number] => 12447191
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-21
[patent_title] => Topical application of polypeptide in the treatment of skin damage
[patent_app_type] => utility
[patent_app_number] => 18/155747
[patent_app_country] => US
[patent_app_date] => 2023-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 0
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18155747
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/155747 | Topical application of polypeptide in the treatment of skin damage | Jan 17, 2023 | Issued |
Array
(
[id] => 19479431
[patent_doc_number] => 20240327473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-03
[patent_title] => TANDEM REPEAT PROTEIN SEQUENCES IN PROTEIN-LIKE POLYMERS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/153872
[patent_app_country] => US
[patent_app_date] => 2023-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36465
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18153872
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/153872 | TANDEM REPEAT PROTEIN SEQUENCES IN PROTEIN-LIKE POLYMERS AND USES THEREOF | Jan 11, 2023 | Pending |
Array
(
[id] => 18725848
[patent_doc_number] => 20230340074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => METHOD OF PURIFYING ALBUMIN-FUSION PROTEINS
[patent_app_type] => utility
[patent_app_number] => 18/150983
[patent_app_country] => US
[patent_app_date] => 2023-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37433
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18150983
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/150983 | METHOD OF PURIFYING ALBUMIN-FUSION PROTEINS | Jan 5, 2023 | Pending |
Array
(
[id] => 18497392
[patent_doc_number] => 20230220022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => HMGN PARTIAL PEPTIDE AND CANCER THERAPY USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/092737
[patent_app_country] => US
[patent_app_date] => 2023-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15497
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 194
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18092737
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/092737 | HMGN partial peptide and cancer therapy using the same | Jan 2, 2023 | Issued |
Array
(
[id] => 18484949
[patent_doc_number] => 20230212264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => COLLAGEN WITH SELECTIVE CHARACTERISTICS, COLLAGEN PRODUCTS CONTAINING SAME AND METHODS FOR PRODUCING SAME
[patent_app_type] => utility
[patent_app_number] => 18/091782
[patent_app_country] => US
[patent_app_date] => 2022-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12398
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18091782
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/091782 | COLLAGEN WITH SELECTIVE CHARACTERISTICS, COLLAGEN PRODUCTS CONTAINING SAME AND METHODS FOR PRODUCING SAME | Dec 29, 2022 | Pending |
Array
(
[id] => 18482867
[patent_doc_number] => 20230210154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => SWEET PROTEIN MUTANTS FROM TRUFFLE
[patent_app_type] => utility
[patent_app_number] => 18/146958
[patent_app_country] => US
[patent_app_date] => 2022-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49562
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18146958
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/146958 | SWEET PROTEIN MUTANTS FROM TRUFFLE | Dec 26, 2022 | Pending |
Array
(
[id] => 18673075
[patent_doc_number] => 20230310547
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => USE OF SOLUBLE PRO(RENIN) RECEPTOR TO TREAT METABOLIC DISORDERS AND RELATED CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 18/145730
[patent_app_country] => US
[patent_app_date] => 2022-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18557
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18145730
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/145730 | Use of soluble pro(renin) receptor to treat metabolic disorders and related conditions | Dec 21, 2022 | Issued |
Array
(
[id] => 19151381
[patent_doc_number] => 11976280
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-07
[patent_title] => SMAC/Diablo inhibitors useful for treating cancer
[patent_app_type] => utility
[patent_app_number] => 18/063397
[patent_app_country] => US
[patent_app_date] => 2022-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 89
[patent_no_of_words] => 34126
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18063397
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/063397 | SMAC/Diablo inhibitors useful for treating cancer | Dec 7, 2022 | Issued |
Array
(
[id] => 18510049
[patent_doc_number] => 20230226147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => COMPOSITION AND METHODS FOR TREATMENT OF PRIMARY CILIARY DYSKINESIA
[patent_app_type] => utility
[patent_app_number] => 18/062435
[patent_app_country] => US
[patent_app_date] => 2022-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26300
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18062435
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/062435 | Composition and methods for treatment of primary ciliary dyskinesia | Dec 5, 2022 | Issued |